NCT00213421 is a clinical trial of Dermoval in Bullous Pemphigoid, sponsored by University Hospital, Rouen.

Who is sponsoring NCT00213421?

NCT00213421 is sponsored by University Hospital, Rouen.

What drugs are being tested in NCT00213421?

Interventions in NCT00213421: Dermoval.

What condition does NCT00213421 study?

NCT00213421 studies Bullous Pemphigoid.

Is NCT00213421 still recruiting?

NCT00213421 is currently completed. Last updated 17 June 2013.

Last reviewed 2013-06-17 · How we verify

NCT00213421

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of Two Therapeutic Strategies of Dermoval in Treatment of Bullous Pemphigus

Completed Last updated 17 June 2013

What this trial tests

trial testing Dermoval in Bullous Pemphigoid in 330 participants. Completed in 1 November 2008.

Timeline

1 August 2001

Primary endpoint
1 October 2004

1 November 2008

Quick facts

Lead sponsor	University Hospital, Rouen
Status	Completed
Study type	OBSERVATIONAL
Enrollment	330
Start date	1 August 2001
Primary completion	1 October 2004
Estimated completion	1 November 2008
Sites	1 location across France

Drugs / interventions tested

Dermoval — full drug profile →

Conditions studied

Bullous Pemphigoid — all drugs for Bullous Pemphigoid →

Sponsor

University Hospital, Rouen

Who can join

18 and older, any sex, with Bullous Pemphigoid. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

to compare efficacity and tolerance of two stratégies of dermoval application in treatment of bullous pemphigus.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Bullous Pemphigoid

Currently open trials in the same condition.

NCT06479018 — Deciphering IL-17-dependant Inflammatory Response in Bullous Pemphigoid · NA · recruiting

Other University Hospital, Rouen trials

Trials by the same sponsor.

NCT07441564 — Evaluation of the Efficacy of Ischemic Preconditioning to Protect Against Acute Kidney Injury After Open Surgery for Jux · NA · not yet recruiting
NCT07535944 — Prospective Exploration of Vascular Complications Associated With the Use of Immune Checkpoint Inhibitors · not yet recruiting
NCT07464184 — Evolution of Hypoxic Burden and Sympathetic/Parasympathetic Balance in Patients With Pulmonary Hypertension · NA · not yet recruiting
NCT07359885 — Prediction of Postoperative Pulmonary Complications in Thoracic Surgery · not yet recruiting
NCT07247500 — Impact of Reventilation After One-Lung Ventilation in Thoracic Surgery (OLVREEXP) · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00213421 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Rouen
Last refreshed: 17 June 2013

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00213421.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing